Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard‐dose subcutaneous maintenance therapyUri Kopylov, David Drobne, Nicola Imperatore et al.|Alimentary Pharmacology & Therapeutics|2020Cited by 80
Genetic Predictors of Benign Course of Ulcerative Colitis—A North American Inflammatory Bowel Disease Genetics Consortium StudyUri Kopylov, Alain Bitton, Gabrielle Boucher et al.|Inflammatory Bowel Diseases|2016Cited by 17